Related Experiment Videos
The atriocaval shunt. Facts and fiction
J M Burch1, D V Feliciano, K L Mattox
1Cora and Webb Mading Department of Surgery, Baylor College of Medicine, Houston, TX 77030.
Annals of Surgery
|May 1, 1988
Summary
The atriocaval shunt treated 31 patients with major juxtahepatic venous injuries, a highly lethal condition. While only 19% survived, this technique offers salvage for some patients when other methods fail.
Area of Science:
- Trauma Surgery
- Vascular Surgery
- Surgical Innovation
Background:
- Major juxtahepatic venous injuries are associated with high mortality rates.
- These injuries often result from penetrating trauma and present with shock.
- Traditional management strategies have limited success in salvaging patients.
Purpose of the Study:
- To evaluate the efficacy and outcomes of using the atriocaval shunt in patients with major juxtahepatic venous injuries.
- To identify factors associated with survival and mortality in this patient cohort.
Main Methods:
- Retrospective analysis of 31 patients treated with an atriocaval shunt over 11 years.
- Inclusion criteria: major juxtahepatic venous injuries.
- Data collected on injury type, patient condition, interventions, and outcomes.
Main Results:
- Twenty-five patients (81%) died from their injuries.
- Six patients (19%) survived, all with retro-hepatic vena cava gunshot wounds.
- Survival was not observed in patients requiring resuscitative thoracotomy, hepatic resection, or experiencing shunt-related technical problems.
Conclusions:
- Major juxtahepatic venous injuries remain highly lethal, with a low survival rate even with the atriocaval shunt.
- The atriocaval shunt provides a potential salvage option when other surgical interventions are not feasible.
- Future improvements in survival may depend on minimizing delays and developing alternative shunting techniques.